Biochemistry · Clinical Enzymology and Organ Function Tests

Plasma cholinesterase (pseudocholinesterase) activity is markedly reduced in a patient prior to surgery. This finding is most clinically significant because it predicts prolonged action of which drug?

  • A Succinylcholine
  • B Vecuronium
  • C Pancuronium
  • D Rocuronium
Correct answer: A. Succinylcholine

Explanation

Succinylcholine (suxamethonium) is a depolarising neuromuscular blocker hydrolysed by plasma pseudocholinesterase. Patients with reduced pseudocholinesterase activity (due to liver disease, inherited dibucaine-resistant variants, organophosphate poisoning, or pregnancy) cannot hydrolyse succinylcholine quickly, resulting in prolonged neuromuscular blockade and apnoea. Vecuronium, pancuronium, and rocuronium are non-depolarising agents eliminated by hepatic metabolism or Hofmann degradation, not by pseudocholinesterase.

Reference: Harper's Illustrated Biochemistry, 32nd ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Clinical Enzymology and Organ Function Tests MCQs

See all Clinical Enzymology and Organ Function Tests MCQs →